OneMedNet Corp. Faces Nasdaq Delisting Notice
Ticker: ONMDW · Form: 8-K · Filed: Aug 16, 2024 · CIK: 1849380
Sentiment: bearish
Topics: delisting, listing-standards, compliance
Related Tickers: ONMD
TL;DR
Nasdaq sent OneMedNet a delisting warning, company's reviewing it.
AI Summary
OneMedNet Corp. announced on August 15, 2024, that it received a notice from the Nasdaq Stock Market indicating a failure to meet continued listing requirements. The company is currently evaluating the notice and plans to respond to Nasdaq.
Why It Matters
This notice signifies potential delisting from Nasdaq, which could negatively impact the company's stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — Receiving a delisting notice from a major exchange like Nasdaq presents a significant risk to the company's market presence and investor relations.
Key Players & Entities
- OneMedNet Corp. (company) — Registrant
- Nasdaq Stock Market (company) — Exchange issuing notice
- August 15, 2024 (date) — Date of earliest event reported
FAQ
What specific continued listing rule did OneMedNet Corp. fail to meet?
The filing does not specify the exact continued listing rule that OneMedNet Corp. failed to meet, only that a notice was received.
What is the exact date of the notice from Nasdaq?
The earliest event reported is August 15, 2024, which is the date of the notice.
What actions will OneMedNet Corp. take in response to the notice?
OneMedNet Corporation is evaluating the notice and intends to respond to Nasdaq.
Has OneMedNet Corp. previously received such notices?
This filing does not provide information on whether OneMedNet Corp. has received previous delisting notices.
What is the company's jurisdiction of incorporation?
OneMedNet Corporation is incorporated in Delaware.
Filing Stats: 503 words · 2 min read · ~2 pages · Grade level 12.5 · Accepted 2024-08-16 16:58:43
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share ONMD The Nasdaq
- $11.50 — of Common Stock at an exercise price of $11.50 per share ONMDW The Nasdaq Stock Ma
Filing Documents
- form8-k.htm (8-K) — 38KB
- 0001493152-24-032853.txt ( ) — 254KB
- onmd-20240815.xsd (EX-101.SCH) — 4KB
- onmd-20240815_def.xml (EX-101.DEF) — 26KB
- onmd-20240815_lab.xml (EX-101.LAB) — 36KB
- onmd-20240815_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 15, 2024 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 6385 Old Shady Oak Road , Suite 250 Eden Prairie , MN 55344 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: 800 - 918-7189 Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value per share ONMD The Nasdaq Stock Market LLC Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share ONMDW The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 15, 2024, OneMedNet Corporation (the "Company") received approval from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") to list its common stock (the "Common Stock") and warrants (the "Warrants") on The Nasdaq Capital Market. The Common Stock and Warrants will be transferred from The Nasdaq Global Market to The Nasdaq Capital Market at the opening of business on August 19, 2024, and will continue to trade under the symbols "ONMD" and "ONMDW," respectively. The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, and listed companies must meet certain financial requirements and comply with Nasdaq's corporate governance requirements. As of August 16, 2024, 31,395,666 shares of the Company's Common Stock are issued and outstanding. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 16, 2024 ONEMEDNET CORPORATION By: /s/ Aaron Green Aaron Green Chief Executive Officer